The Procter & Gamble Company, Cincinnati, Ohio, USA.
Crit Rev Toxicol. 2011 Jul;41(6):507-44. doi: 10.3109/10408444.2011.552063. Epub 2011 May 18.
Quantitative methods for estimation of cancer risk have been developed for daily, lifetime human exposures. There are a variety of studies or methodologies available to address less-than-lifetime exposures. However, a common framework for evaluating risk from less-than-lifetime exposures (including short-term and/or intermittent exposures) does not exist, which could result in inconsistencies in risk assessment practice. To address this risk assessment need, a committee of the International Life Sciences Institute (ILSI) Health and Environmental Sciences Institute conducted a multisector workshop in late 2009 to discuss available literature, different methodologies, and a proposed framework. The proposed framework provides a decision tree and guidance for cancer risk assessments for less-than-lifetime exposures based on current knowledge of mode of action and dose-response. Available data from rodent studies and epidemiological studies involving less-than-lifetime exposures are considered, in addition to statistical approaches described in the literature for evaluating the impact of changing the dose rate and exposure duration for exposure to carcinogens. The decision tree also provides for scenarios in which an assumption of potential carcinogenicity is appropriate (e.g., based on structural alerts or genotoxicity data), but bioassay or other data are lacking from which a chemical-specific cancer potency can be determined. This paper presents an overview of the rationale for the workshop, reviews historical background, describes the proposed framework for assessing less-than-lifetime exposures to potential human carcinogens, and suggests next steps.
已开发出用于日常和终生人体暴露的癌症风险定量评估方法。有多种研究或方法可用于解决非终生暴露问题。然而,对于非终生暴露(包括短期和/或间歇性暴露),目前尚不存在评估风险的通用框架,这可能导致风险评估实践存在不一致性。为了解决这一风险评估需求,国际生命科学学会(ILSI)健康与环境科学研究所的一个委员会于 2009 年末举办了一次多部门研讨会,讨论现有文献、不同方法以及一个拟议框架。该拟议框架根据作用模式和剂量反应的现有知识,为非终生暴露的癌症风险评估提供了决策树和指导。除了文献中描述的用于评估改变致癌物剂量率和暴露持续时间对暴露影响的统计方法外,还考虑了来自啮齿动物研究和涉及非终生暴露的流行病学研究的现有数据。决策树还为假设潜在致癌性的情况提供了依据(例如,基于结构警报或遗传毒性数据),但缺乏生物测定或其他数据,无法确定特定化学物质的癌症效力。本文概述了研讨会的基本原理,回顾了历史背景,描述了评估潜在人类致癌物非终生暴露的拟议框架,并提出了下一步建议。